IRS gets $1.1 billion in transfer pricing case

U.K. based AstraZeneca plc announced that it will pay the Internal Revenue Service $1.1 billion to settle all transfer pricing issues for 2000-10, according to a March 28 statement released by the company.

Tax authorities in the U.S. and the U.K. agreed on an advance pricing agreement regarding transfers between AstraZeneca’s international subsidiaries for the period from 2002 through 2014, the company said. AstraZeneca also agreed with U.S. tax authorities on a related valuation matter stemming from the integration of its U.S. businesses after the merger that created the company in 1999.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s